Global Therapeutic BCG Vaccines Market Insights, Forecast to 2029

Therapeutic BCG Vaccines Market

The global Therapeutic BCG Vaccines market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Therapeutic BCG Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Therapeutic BCG Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Therapeutic BCG Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Therapeutic BCG Vaccines include Merck, Sanofi Pasteur (Sanofi), Japan BCG Lab, Serum Institute of India, Intervax and GSBPL, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Therapeutic BCG Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Therapeutic BCG Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Therapeutic BCG Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic BCG Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Therapeutic BCG Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Therapeutic BCG Vaccines sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Merck, Sanofi Pasteur (Sanofi), Japan BCG Lab, Serum Institute of India, Intervax and GSBPL, etc.

Scope of Therapeutic BCG Vaccines Market Report

Chapter Outline

1.1 Therapeutic BCG Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Therapeutic BCG Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 0.5ml Package

1.2.3 1ml Package

1.2.4 2ml Package

1.2.5 Other

1.3 Market by Application

1.3.1 Global Therapeutic BCG Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Therapeutic BCG Vaccines Sales Estimates and Forecasts 2018-2029

2.2 Global Therapeutic BCG Vaccines Revenue by Region

2.2.1 Global Therapeutic BCG Vaccines Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Therapeutic BCG Vaccines Revenue by Region (2018-2023)

2.2.3 Global Therapeutic BCG Vaccines Revenue by Region (2024-2029)

2.2.4 Global Therapeutic BCG Vaccines Revenue Market Share by Region (2018-2029)

2.3 Global Therapeutic BCG Vaccines Sales Estimates and Forecasts 2018-2029

2.4 Global Therapeutic BCG Vaccines Sales by Region

2.4.1 Global Therapeutic BCG Vaccines Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Therapeutic BCG Vaccines Sales by Region (2018-2023)

2.4.3 Global Therapeutic BCG Vaccines Sales by Region (2024-2029)

2.4.4 Global Therapeutic BCG Vaccines Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3.1 Global Therapeutic BCG Vaccines Sales by Manufacturers

3.1.1 Global Therapeutic BCG Vaccines Sales by Manufacturers (2018-2023)

3.1.2 Global Therapeutic BCG Vaccines Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic BCG Vaccines in 2022

3.2 Global Therapeutic BCG Vaccines Revenue by Manufacturers

3.2.1 Global Therapeutic BCG Vaccines Revenue by Manufacturers (2018-2023)

3.2.2 Global Therapeutic BCG Vaccines Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Therapeutic BCG Vaccines Revenue in 2022

3.3 Global Key Players of Therapeutic BCG Vaccines, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Therapeutic BCG Vaccines Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Therapeutic BCG Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Therapeutic BCG Vaccines, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Therapeutic BCG Vaccines, Product Offered and Application

3.8 Global Key Manufacturers of Therapeutic BCG Vaccines, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4.1 Global Therapeutic BCG Vaccines Sales by Type

4.1.1 Global Therapeutic BCG Vaccines Historical Sales by Type (2018-2023)

4.1.2 Global Therapeutic BCG Vaccines Forecasted Sales by Type (2024-2029)

4.1.3 Global Therapeutic BCG Vaccines Sales Market Share by Type (2018-2029)

4.2 Global Therapeutic BCG Vaccines Revenue by Type

4.2.1 Global Therapeutic BCG Vaccines Historical Revenue by Type (2018-2023)

4.2.2 Global Therapeutic BCG Vaccines Forecasted Revenue by Type (2024-2029)

4.2.3 Global Therapeutic BCG Vaccines Revenue Market Share by Type (2018-2029)

4.3 Global Therapeutic BCG Vaccines Price by Type

4.3.1 Global Therapeutic BCG Vaccines Price by Type (2018-2023)

4.3.2 Global Therapeutic BCG Vaccines Price Forecast by Type (2024-2029)

5.1 Global Therapeutic BCG Vaccines Sales by Application

5.1.1 Global Therapeutic BCG Vaccines Historical Sales by Application (2018-2023)

5.1.2 Global Therapeutic BCG Vaccines Forecasted Sales by Application (2024-2029)

5.1.3 Global Therapeutic BCG Vaccines Sales Market Share by Application (2018-2029)

5.2 Global Therapeutic BCG Vaccines Revenue by Application

5.2.1 Global Therapeutic BCG Vaccines Historical Revenue by Application (2018-2023)

5.2.2 Global Therapeutic BCG Vaccines Forecasted Revenue by Application (2024-2029)

5.2.3 Global Therapeutic BCG Vaccines Revenue Market Share by Application (2018-2029)

5.3 Global Therapeutic BCG Vaccines Price by Application

5.3.1 Global Therapeutic BCG Vaccines Price by Application (2018-2023)

5.3.2 Global Therapeutic BCG Vaccines Price Forecast by Application (2024-2029)

6.1 US & Canada Therapeutic BCG Vaccines Market Size by Type

6.1.1 US & Canada Therapeutic BCG Vaccines Sales by Type (2018-2029)

6.1.2 US & Canada Therapeutic BCG Vaccines Revenue by Type (2018-2029)

6.2 US & Canada Therapeutic BCG Vaccines Market Size by Application

6.2.1 US & Canada Therapeutic BCG Vaccines Sales by Application (2018-2029)

6.2.2 US & Canada Therapeutic BCG Vaccines Revenue by Application (2018-2029)

6.3 US & Canada Therapeutic BCG Vaccines Market Size by Country

6.3.1 US & Canada Therapeutic BCG Vaccines Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Therapeutic BCG Vaccines Sales by Country (2018-2029)

6.3.3 US & Canada Therapeutic BCG Vaccines Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7.1 Europe Therapeutic BCG Vaccines Market Size by Type

7.1.1 Europe Therapeutic BCG Vaccines Sales by Type (2018-2029)

7.1.2 Europe Therapeutic BCG Vaccines Revenue by Type (2018-2029)

7.2 Europe Therapeutic BCG Vaccines Market Size by Application

7.2.1 Europe Therapeutic BCG Vaccines Sales by Application (2018-2029)

7.2.2 Europe Therapeutic BCG Vaccines Revenue by Application (2018-2029)

7.3 Europe Therapeutic BCG Vaccines Market Size by Country

7.3.1 Europe Therapeutic BCG Vaccines Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Therapeutic BCG Vaccines Sales by Country (2018-2029)

7.3.3 Europe Therapeutic BCG Vaccines Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8.1 China Therapeutic BCG Vaccines Market Size

8.1.1 China Therapeutic BCG Vaccines Sales (2018-2029)

8.1.2 China Therapeutic BCG Vaccines Revenue (2018-2029)

8.2 China Therapeutic BCG Vaccines Market Size by Application

8.2.1 China Therapeutic BCG Vaccines Sales by Application (2018-2029)

8.2.2 China Therapeutic BCG Vaccines Revenue by Application (2018-2029)

9.1 Asia Therapeutic BCG Vaccines Market Size by Type

9.1.1 Asia Therapeutic BCG Vaccines Sales by Type (2018-2029)

9.1.2 Asia Therapeutic BCG Vaccines Revenue by Type (2018-2029)

9.2 Asia Therapeutic BCG Vaccines Market Size by Application

9.2.1 Asia Therapeutic BCG Vaccines Sales by Application (2018-2029)

9.2.2 Asia Therapeutic BCG Vaccines Revenue by Application (2018-2029)

9.3 Asia Therapeutic BCG Vaccines Sales by Region

9.3.1 Asia Therapeutic BCG Vaccines Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Therapeutic BCG Vaccines Revenue by Region (2018-2029)

9.3.3 Asia Therapeutic BCG Vaccines Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10.1 Middle East, Africa and Latin America Therapeutic BCG Vaccines Market Size by Type

10.1.1 Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Therapeutic BCG Vaccines Market Size by Application

10.2.1 Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Country

10.3.1 Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11.1 Merck

11.1.1 Merck Company Information

11.1.2 Merck Overview

11.1.3 Merck Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 Merck Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Merck Recent Developments

11.2 Sanofi Pasteur (Sanofi)

11.2.1 Sanofi Pasteur (Sanofi) Company Information

11.2.2 Sanofi Pasteur (Sanofi) Overview

11.2.3 Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Sanofi Pasteur (Sanofi) Recent Developments

11.3 Japan BCG Lab

11.3.1 Japan BCG Lab Company Information

11.3.2 Japan BCG Lab Overview

11.3.3 Japan BCG Lab Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Japan BCG Lab Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Japan BCG Lab Recent Developments

11.4 Serum Institute of India

11.4.1 Serum Institute of India Company Information

11.4.2 Serum Institute of India Overview

11.4.3 Serum Institute of India Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 Serum Institute of India Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Serum Institute of India Recent Developments

11.5 Intervax

11.5.1 Intervax Company Information

11.5.2 Intervax Overview

11.5.3 Intervax Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Intervax Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Intervax Recent Developments

11.6 GSBPL

11.6.1 GSBPL Company Information

11.6.2 GSBPL Overview

11.6.3 GSBPL Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 GSBPL Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 GSBPL Recent Developments

12.1 Therapeutic BCG Vaccines Industry Chain Analysis

12.2 Therapeutic BCG Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Therapeutic BCG Vaccines Production Mode & Process

12.4 Therapeutic BCG Vaccines Sales and Marketing

12.4.1 Therapeutic BCG Vaccines Sales Channels

12.4.2 Therapeutic BCG Vaccines Distributors

12.5 Therapeutic BCG Vaccines Customers

13.1 Therapeutic BCG Vaccines Industry Trends

13.2 Therapeutic BCG Vaccines Market Drivers

13.3 Therapeutic BCG Vaccines Market Challenges

13.4 Therapeutic BCG Vaccines Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Therapeutic BCG Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Table 2. Major Manufacturers of 0.5ml Package

    Table 3. Major Manufacturers of 1ml Package

    Table 4. Major Manufacturers of 2ml Package

    Table 5. Major Manufacturers of Other

    Table 6. Global Therapeutic BCG Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Table 7. Global Therapeutic BCG Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 8. Global Therapeutic BCG Vaccines Revenue by Region (2018-2023) & (US$ Million)

    Table 9. Global Therapeutic BCG Vaccines Revenue by Region (2024-2029) & (US$ Million)

    Table 10. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2018-2023)

    Table 11. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2024-2029)

    Table 12. Global Therapeutic BCG Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 13. Global Therapeutic BCG Vaccines Sales by Region (2018-2023) & (Kg)

    Table 14. Global Therapeutic BCG Vaccines Sales by Region (2024-2029) & (Kg)

    Table 15. Global Therapeutic BCG Vaccines Sales Market Share by Region (2018-2023)

    Table 16. Global Therapeutic BCG Vaccines Sales Market Share by Region (2024-2029)

    Table 17. Global Therapeutic BCG Vaccines Sales by Manufacturers (2018-2023) & (Kg)

    Table 18. Global Therapeutic BCG Vaccines Sales Share by Manufacturers (2018-2023)

    Table 19. Global Therapeutic BCG Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)

    Table 20. Global Therapeutic BCG Vaccines Revenue Share by Manufacturers (2018-2023)

    Table 21. Global Key Players of Therapeutic BCG Vaccines, Industry Ranking, 2021 VS 2022 VS 2023

    Table 22. Therapeutic BCG Vaccines Price by Manufacturers 2018-2023 (USD/g)

    Table 23. Global Therapeutic BCG Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 24. Global Therapeutic BCG Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic BCG Vaccines as of 2022)

    Table 25. Global Key Manufacturers of Therapeutic BCG Vaccines, Manufacturing Base Distribution and Headquarters

    Table 26. Global Key Manufacturers of Therapeutic BCG Vaccines, Product Offered and Application

    Table 27. Global Key Manufacturers of Therapeutic BCG Vaccines, Date of Enter into This Industry

    Table 28. Mergers & Acquisitions, Expansion Plans

    Table 29. Global Therapeutic BCG Vaccines Sales by Type (2018-2023) & (Kg)

    Table 30. Global Therapeutic BCG Vaccines Sales by Type (2024-2029) & (Kg)

    Table 31. Global Therapeutic BCG Vaccines Sales Share by Type (2018-2023)

    Table 32. Global Therapeutic BCG Vaccines Sales Share by Type (2024-2029)

    Table 33. Global Therapeutic BCG Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 34. Global Therapeutic BCG Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 35. Global Therapeutic BCG Vaccines Revenue Share by Type (2018-2023)

    Table 36. Global Therapeutic BCG Vaccines Revenue Share by Type (2024-2029)

    Table 37. Therapeutic BCG Vaccines Price by Type (2018-2023) & (USD/g)

    Table 38. Global Therapeutic BCG Vaccines Price Forecast by Type (2024-2029) & (USD/g)

    Table 39. Global Therapeutic BCG Vaccines Sales by Application (2018-2023) & (Kg)

    Table 40. Global Therapeutic BCG Vaccines Sales by Application (2024-2029) & (Kg)

    Table 41. Global Therapeutic BCG Vaccines Sales Share by Application (2018-2023)

    Table 42. Global Therapeutic BCG Vaccines Sales Share by Application (2024-2029)

    Table 43. Global Therapeutic BCG Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 44. Global Therapeutic BCG Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 45. Global Therapeutic BCG Vaccines Revenue Share by Application (2018-2023)

    Table 46. Global Therapeutic BCG Vaccines Revenue Share by Application (2024-2029)

    Table 47. Therapeutic BCG Vaccines Price by Application (2018-2023) & (USD/g)

    Table 48. Global Therapeutic BCG Vaccines Price Forecast by Application (2024-2029) & (USD/g)

    Table 49. US & Canada Therapeutic BCG Vaccines Sales by Type (2018-2023) & (Kg)

    Table 50. US & Canada Therapeutic BCG Vaccines Sales by Type (2024-2029) & (Kg)

    Table 51. US & Canada Therapeutic BCG Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 52. US & Canada Therapeutic BCG Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 53. US & Canada Therapeutic BCG Vaccines Sales by Application (2018-2023) & (Kg)

    Table 54. US & Canada Therapeutic BCG Vaccines Sales by Application (2024-2029) & (Kg)

    Table 55. US & Canada Therapeutic BCG Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 56. US & Canada Therapeutic BCG Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 57. US & Canada Therapeutic BCG Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 58. US & Canada Therapeutic BCG Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 59. US & Canada Therapeutic BCG Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 60. US & Canada Therapeutic BCG Vaccines Sales by Country (2018-2023) & (Kg)

    Table 61. US & Canada Therapeutic BCG Vaccines Sales by Country (2024-2029) & (Kg)

    Table 62. Europe Therapeutic BCG Vaccines Sales by Type (2018-2023) & (Kg)

    Table 63. Europe Therapeutic BCG Vaccines Sales by Type (2024-2029) & (Kg)

    Table 64. Europe Therapeutic BCG Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 65. Europe Therapeutic BCG Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 66. Europe Therapeutic BCG Vaccines Sales by Application (2018-2023) & (Kg)

    Table 67. Europe Therapeutic BCG Vaccines Sales by Application (2024-2029) & (Kg)

    Table 68. Europe Therapeutic BCG Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 69. Europe Therapeutic BCG Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 70. Europe Therapeutic BCG Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 71. Europe Therapeutic BCG Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 72. Europe Therapeutic BCG Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 73. Europe Therapeutic BCG Vaccines Sales by Country (2018-2023) & (Kg)

    Table 74. Europe Therapeutic BCG Vaccines Sales by Country (2024-2029) & (Kg)

    Table 75. China Therapeutic BCG Vaccines Sales by Type (2018-2023) & (Kg)

    Table 76. China Therapeutic BCG Vaccines Sales by Type (2024-2029) & (Kg)

    Table 77. China Therapeutic BCG Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 78. China Therapeutic BCG Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 79. China Therapeutic BCG Vaccines Sales by Application (2018-2023) & (Kg)

    Table 80. China Therapeutic BCG Vaccines Sales by Application (2024-2029) & (Kg)

    Table 81. China Therapeutic BCG Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 82. China Therapeutic BCG Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 83. Asia Therapeutic BCG Vaccines Sales by Type (2018-2023) & (Kg)

    Table 84. Asia Therapeutic BCG Vaccines Sales by Type (2024-2029) & (Kg)

    Table 85. Asia Therapeutic BCG Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 86. Asia Therapeutic BCG Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 87. Asia Therapeutic BCG Vaccines Sales by Application (2018-2023) & (Kg)

    Table 88. Asia Therapeutic BCG Vaccines Sales by Application (2024-2029) & (Kg)

    Table 89. Asia Therapeutic BCG Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 90. Asia Therapeutic BCG Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 91. Asia Therapeutic BCG Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 92. Asia Therapeutic BCG Vaccines Revenue by Region (2018-2023) & (US$ Million)

    Table 93. Asia Therapeutic BCG Vaccines Revenue by Region (2024-2029) & (US$ Million)

    Table 94. Asia Therapeutic BCG Vaccines Sales by Region (2018-2023) & (Kg)

    Table 95. Asia Therapeutic BCG Vaccines Sales by Region (2024-2029) & (Kg)

    Table 96. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Type (2018-2023) & (Kg)

    Table 97. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Type (2024-2029) & (Kg)

    Table 98. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Type (2018-2023) & (US$ Million)

    Table 99. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Type (2024-2029) & (US$ Million)

    Table 100. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Application (2018-2023) & (Kg)

    Table 101. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Application (2024-2029) & (Kg)

    Table 102. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Application (2018-2023) & (US$ Million)

    Table 103. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Application (2024-2029) & (US$ Million)

    Table 104. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 105. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 106. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 107. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Country (2018-2023) & (Kg)

    Table 108. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales by Country (2024-2029) & (Kg)

    Table 109. Merck Company Information

    Table 110. Merck Description and Major Businesses

    Table 111. Merck Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 112. Merck Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 113. Merck Recent Developments

    Table 114. Sanofi Pasteur (Sanofi) Company Information

    Table 115. Sanofi Pasteur (Sanofi) Description and Major Businesses

    Table 116. Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 117. Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 118. Sanofi Pasteur (Sanofi) Recent Developments

    Table 119. Japan BCG Lab Company Information

    Table 120. Japan BCG Lab Description and Major Businesses

    Table 121. Japan BCG Lab Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 122. Japan BCG Lab Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 123. Japan BCG Lab Recent Developments

    Table 124. Serum Institute of India Company Information

    Table 125. Serum Institute of India Description and Major Businesses

    Table 126. Serum Institute of India Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 127. Serum Institute of India Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 128. Serum Institute of India Recent Developments

    Table 129. Intervax Company Information

    Table 130. Intervax Description and Major Businesses

    Table 131. Intervax Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 132. Intervax Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 133. Intervax Recent Developments

    Table 134. GSBPL Company Information

    Table 135. GSBPL Description and Major Businesses

    Table 136. GSBPL Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 137. GSBPL Therapeutic BCG Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

    Table 138. GSBPL Recent Developments

    Table 139. Key Raw Materials Lists

    Table 140. Raw Materials Key Suppliers Lists

    Table 141. Therapeutic BCG Vaccines Distributors List

    Table 142. Therapeutic BCG Vaccines Customers List

    Table 143. Therapeutic BCG Vaccines Market Trends

    Table 144. Therapeutic BCG Vaccines Market Drivers

    Table 145. Therapeutic BCG Vaccines Market Challenges

    Table 146. Therapeutic BCG Vaccines Market Restraints

    Table 147. Research Programs/Design for This Report

    Table 148. Key Data Information from Secondary Sources

    Table 149. Key Data Information from Primary Sources

List of Figures

    Figure 1. Therapeutic BCG Vaccines Product Picture

    Figure 2. Global Therapeutic BCG Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 3. Global Therapeutic BCG Vaccines Market Share by Type in 2022 & 2029

    Figure 4. 0.5ml Package Product Picture

    Figure 5. 1ml Package Product Picture

    Figure 6. 2ml Package Product Picture

    Figure 7. Other Product Picture

    Figure 8. Global Therapeutic BCG Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 9. Global Therapeutic BCG Vaccines Market Share by Application in 2022 & 2029

    Figure 10. Hospitals

    Figure 11. Clinics

    Figure 12. Others

    Figure 13. Therapeutic BCG Vaccines Report Years Considered

    Figure 14. Global Therapeutic BCG Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Therapeutic BCG Vaccines Revenue 2018-2029 (US$ Million)

    Figure 16. Global Therapeutic BCG Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029

    Figure 17. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2018-2029)

    Figure 18. Global Therapeutic BCG Vaccines Sales 2018-2029 ((Kg)

    Figure 19. Global Therapeutic BCG Vaccines Sales Market Share by Region (2018-2029)

    Figure 20. US & Canada Therapeutic BCG Vaccines Sales YoY (2018-2029) & (Kg)

    Figure 21. US & Canada Therapeutic BCG Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 22. Europe Therapeutic BCG Vaccines Sales YoY (2018-2029) & (Kg)

    Figure 23. Europe Therapeutic BCG Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 24. China Therapeutic BCG Vaccines Sales YoY (2018-2029) & (Kg)

    Figure 25. China Therapeutic BCG Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 26. Asia (excluding China) Therapeutic BCG Vaccines Sales YoY (2018-2029) & (Kg)

    Figure 27. Asia (excluding China) Therapeutic BCG Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 28. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales YoY (2018-2029) & (Kg)

    Figure 29. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue YoY (2018-2029) & (US$ Million)

    Figure 30. The Therapeutic BCG Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

    Figure 31. The Top 5 and 10 Largest Manufacturers of Therapeutic BCG Vaccines in the World: Market Share by Therapeutic BCG Vaccines Revenue in 2022

    Figure 32. Global Therapeutic BCG Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

    Figure 33. Global Therapeutic BCG Vaccines Sales Market Share by Type (2018-2029)

    Figure 34. Global Therapeutic BCG Vaccines Revenue Market Share by Type (2018-2029)

    Figure 35. Global Therapeutic BCG Vaccines Sales Market Share by Application (2018-2029)

    Figure 36. Global Therapeutic BCG Vaccines Revenue Market Share by Application (2018-2029)

    Figure 37. US & Canada Therapeutic BCG Vaccines Sales Market Share by Type (2018-2029)

    Figure 38. US & Canada Therapeutic BCG Vaccines Revenue Market Share by Type (2018-2029)

    Figure 39. US & Canada Therapeutic BCG Vaccines Sales Market Share by Application (2018-2029)

    Figure 40. US & Canada Therapeutic BCG Vaccines Revenue Market Share by Application (2018-2029)

    Figure 41. US & Canada Therapeutic BCG Vaccines Revenue Share by Country (2018-2029)

    Figure 42. US & Canada Therapeutic BCG Vaccines Sales Share by Country (2018-2029)

    Figure 43. U.S. Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 44. Canada Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 45. Europe Therapeutic BCG Vaccines Sales Market Share by Type (2018-2029)

    Figure 46. Europe Therapeutic BCG Vaccines Revenue Market Share by Type (2018-2029)

    Figure 47. Europe Therapeutic BCG Vaccines Sales Market Share by Application (2018-2029)

    Figure 48. Europe Therapeutic BCG Vaccines Revenue Market Share by Application (2018-2029)

    Figure 49. Europe Therapeutic BCG Vaccines Revenue Share by Country (2018-2029)

    Figure 50. Europe Therapeutic BCG Vaccines Sales Share by Country (2018-2029)

    Figure 51. Germany Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 52. France Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 53. U.K. Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 54. Italy Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 55. Russia Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 56. China Therapeutic BCG Vaccines Sales Market Share by Type (2018-2029)

    Figure 57. China Therapeutic BCG Vaccines Revenue Market Share by Type (2018-2029)

    Figure 58. China Therapeutic BCG Vaccines Sales Market Share by Application (2018-2029)

    Figure 59. China Therapeutic BCG Vaccines Revenue Market Share by Application (2018-2029)

    Figure 60. Asia Therapeutic BCG Vaccines Sales Market Share by Type (2018-2029)

    Figure 61. Asia Therapeutic BCG Vaccines Revenue Market Share by Type (2018-2029)

    Figure 62. Asia Therapeutic BCG Vaccines Sales Market Share by Application (2018-2029)

    Figure 63. Asia Therapeutic BCG Vaccines Revenue Market Share by Application (2018-2029)

    Figure 64. Asia Therapeutic BCG Vaccines Revenue Share by Region (2018-2029)

    Figure 65. Asia Therapeutic BCG Vaccines Sales Share by Region (2018-2029)

    Figure 66. Japan Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 67. South Korea Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 68. China Taiwan Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 69. Southeast Asia Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 70. India Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 71. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales Market Share by Type (2018-2029)

    Figure 72. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue Market Share by Type (2018-2029)

    Figure 73. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales Market Share by Application (2018-2029)

    Figure 74. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue Market Share by Application (2018-2029)

    Figure 75. Middle East, Africa and Latin America Therapeutic BCG Vaccines Revenue Share by Country (2018-2029)

    Figure 76. Middle East, Africa and Latin America Therapeutic BCG Vaccines Sales Share by Country (2018-2029)

    Figure 77. Brazil Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 78. Mexico Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 79. Turkey Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 80. Israel Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 81. GCC Countries Therapeutic BCG Vaccines Revenue (2018-2029) & (US$ Million)

    Figure 82. Therapeutic BCG Vaccines Value Chain

    Figure 83. Therapeutic BCG Vaccines Production Process

    Figure 84. Channels of Distribution

    Figure 85. Distributors Profiles

    Figure 86. Bottom-up and Top-down Approaches for This Report

    Figure 87. Data Triangulation

    Figure 88. Key Executives Interviewed